Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

Chief Executive Officer

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neuro...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-19	Premium	bought	Premium	Premium	Premium	-
2024-04-01	Premium	bought	Premium	Premium	Premium	-
2024-01-23	Premium	sold	Premium	Premium	Premium	-
2024-01-05	Premium	bought	Premium	Premium	Premium	-
2024-01-05	Premium	bought	Premium	Premium	Premium	-
2023-12-26	Premium	bought	Premium	Premium	Premium	-
2023-12-22	Premium	bought	Premium	Premium	Premium	-
2023-09-26	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2023-05-24	Premium	bought	Premium	Premium	Premium	-
2023-04-28	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-03-22	Premium	bought	Premium	Premium	Premium	-
2023-03-17	Premium	bought	Premium	Premium	Premium	-
2023-03-16	Premium	bought	Premium	Premium	Premium	-
2023-02-24	Premium	acquired	Premium	Premium	Premium	-
2023-02-15	Premium	bought	Premium	Premium	Premium	-
2022-12-28	Premium	bought	Premium	Premium	Premium	-
2022-12-27	Premium	bought	Premium	Premium	Premium	-
2022-12-21	Premium	bought	Premium	Premium	Premium	-
2022-12-19	Premium	bought	Premium	Premium	Premium	-
2022-12-19	Premium	bought	Premium	Premium	Premium	-
2022-12-16	Premium	bought	Premium	Premium	Premium	-
2022-11-18	Premium	bought	Premium	Premium	Premium	-
2022-11-11	Premium	acquired	Premium	Premium	Premium	-
2022-11-02	Premium	bought	Premium	Premium	Premium	-
2022-10-31	Premium	bought	Premium	Premium	Premium	-

ALZN - Alzamend Neuro, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for ALZN